Neuren Pharmaceuticals
Immutep
Pharmaxis
Imugene
Noxopharm
dorsaVi
ASX health stocks: dorsaVi leads the pack with 12% jump on major contract extension
Pharmaxis welcomes data presented by University of Rochester showing PXS-5505 decreases tumour burden in pre-clinical liver cancer model
Lithium Australia
Lithium Australia raises $1.7 million through placement with Acuity Capital
Imugene enters into strategic partnership with Celularity to develop immunotherapy for solid tumors
Centuria Capital Group
Nick Scali
Dubber Corp
ELMO Software
ASX 200 opens lower but recovers swiftly
Deep Yellow
Toro Energy
Deep Yellow reports thick uranium hit as Japan agency firms support
Aldoro Resources
Aldoro grows lithium land holdings in WA
Nick Scali doubles full-year profit
Musgrave Minerals
Silver City Minerals
Silver City jumps straight into gold drilling to follow up 6m @ 15 g/t at Austin
Why the Immutep (ASX:IMM) share price is charging higher today